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The Novel Zinc Finger-Containing Transcription
Factor Osterix Is Required for Osteoblast
Differentiation and Bone Formation
blasts derive from a common precursor (Fang and Hall,
1997).
Chondrocytes deposit a cartilage-specific extracellu-
lar matrix, proliferate, and, in most cases, hypertrophy
and die. At the same time, some of the mesenchymal
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cells surrounding cartilages invade, together with bloodProgram in Genes and Development
vessels and osteoclasts, zones of hypertrophic chon-M. D. Anderson Cancer Center
drocytes, differentiate into osteoblasts, and deposit aUniversity of Texas
bone-specific matrix, replacing the degraded cartilage1515 Holcombe Boulevard
matrix. Interestingly, differentiation of osteoblasts inHouston, Texas 77030
membranous skeletal elements begins concurrently
with that in the endochondral skeleton, suggesting a
temporal control synchronizing both modes of bone for-
Summary mation. Three members of the Sox family of transcription
factors, Sox9, L-Sox5, and Sox6, which are needed for
We have identified a novel zinc finger-containing tran- two successive steps of chondrocyte differentiation,
scription factor, called Osterix (Osx), that is specifi- control the fate of the chondrocyte lineage (Bi et al.,
cally expressed in all developing bones. In Osx null 1999; Smits et al., 2001).
mice, no bone formation occurs. In endochondral skel- The transcription factor, Runx2/Cbfa1, a runt family
etal elements of Osx null mice, mesenchymal cells, polypeptide, has previously been shown to be required
together with osteoclasts and blood vessels, invade for osteoblast differentiation. In Runx2/Cbfa1 null mice,
the mineralized cartilage matrix. However, the mesen- osteoblast differentiation is arrested in both the endo-
chymal cells do not deposit bone matrix. Similarly, chondral and intramembranous skeleton (Komori et al.,
cells in the periosteum and in the condensed mesen- 1997; Otto et al., 1997). In addition, Runx2/Cbfa1 also
chyme of membranous skeletal elements cannot dif- has a positive role in the differentiation of hypertrophic
ferentiate into osteoblasts. These cells do, however, chondrocytes, a property that should prime the process
express Runx2/Cbfa1, another transcription factor re- by which the cartilaginous skeleton is replaced by bone
quired for bone formation. In contrast, Osx is not ex- (Inada et al., 1999; Kim et al., 1999; Ueta et al., 2001).
pressed in Runx2/Cbfa1 null mice. Thus, Osx acts Another polypeptide, Indian hedgehog (Ihh), a member
downstream of Runx2/Cbfa1. Because Osx null preos- of the Hedgehog family of secreted proteins, is required
teoblasts express typical chondrocyte marker genes, for endochondral but not for intramembranous ossifica-
we propose that Runx2/Cbfa1-expressing preosteo- tion (St. Jacques et al., 1999). It was proposed that
blasts are still bipotential cells. Ihh is needed for the establishment of the osteogenic
portion of the perichondrium/periosteum acting up-
stream of Runx2/Cbfa1. This and additional roles of IhhIntroduction
coordinate several critical events in endochondral bone
formation.The development of vertebrate endoskeletons is initially
Establishment of cell lineages involves several differ-
controlled by molecular signals that provide patterning
entiation steps. For instance, in the differentiation of
information to the mesenchyme in order to generate
myoblasts (Black and Olson, 1998), adipocytes (Rosen
primordia of individual skeletal elements (Tickle, 1995; and Spiegelman, 2000) and chondrocytes, distinct tran-
Johnson and Tabin, 1997). These signals outline the scription factors control discrete differentiation steps.
three-dimensional coordinates that determine the shape Hence, we have postulated that in the differentiation of
of mesenchymal condensations. Among the molecules osteoblasts, other transcription factors, in addition to
that pattern skeletal elements are secreted polypeptides Runx2/Cbfa1, might be required. To identify such tran-
of the Hedgehog, Wnt, and FGF families, and of the scription factors, we have designed a simple screen to
TGF- superfamily, as well as transcription factors of isolate cDNAs that are osteoblast-specific. This screen
the Pax, Hox, homeodomain-containing, bHLH, and has identified a novel zinc finger-containing transcrip-
Forkhead families (Karsenty, 1999; DeLise et al., 2000; tion factor called Osterix (Osx) that is expressed in os-
Olsen et al., 2000). In membranous skeletal elements, teoblasts of all endochondral and membranous bones.
cells in condensations differentiate into osteoblasts, In Osx null mutant mice, no endochondral and no intra-
whereas in endochondral skeletal elements, cells in con- membranous bone formation occur. Arrest in osteoblast
densations differentiate into chondrocytes to form the differentiation occurs at a later step than in Runx2/Cbfa1
cartilages that will later be replaced by bones. It has null mice.
been suggested that both chondrocytes and osteo-
Results
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Cloning of cDNA for Osterix2 These authors made equal contributions to this work.
When C2C12 skeletal muscle progenitor cells become3 Present address: Department of Biochemistry and Biophysics,
Texas A&M University, College Station, Texas 77843 confluent in culture, they fuse into typical multinucleated
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myotubes. However, upon BMP-2 addition, these cells cells of the tooth germ also showed a positive signal,
whereas no expression was detected in the epithelialtransdifferentiate into osteoblasts (Katagiri et al., 1994).
To identify potential osteoblast-specific proteins, we tissue of the tooth germs and Meckel’s cartilage. In
13-day-old mice, expression remained strong in boneused a two-step screen consisting of a PCR-based sup-
pression-subtractive hybridization followed by differen- trabeculae and in secondary ossification centers. At this
stage, cells either within the bone matrix or associatedtial hybridization. A cDNA clone from this screen hybrid-
ized with a 3 kb RNA that was induced early after BMP-2 with the inner (endosteum) and outer (periosteum) bone
surfaces were positive for Osx expression.addition to C2C12 cells, at about the same time that
Runx2/Cbfa1 RNA could be detected, but much earlier
than RNA for the late osteoblast marker osteocalcin was Biochemical Characterization
expressed (for detailed results, see Supplemental Data of Recombinant Osx
at http://www.cell.com/cgi/content/full/108/1/17/DC1). The three zinc finger motif located at the C-terminal part
Osx was expressed in ROS17/2.8 and MC3T3-E1 osteo- of Osx and its high degree of sequence homology with
blast cell lines and in rat chondrosarcoma cells. How- a similar motif in Sp1, Sp3, and Sp4 strongly suggested
ever, Osx was not expressed in Balb3T3 fibroblasts, that Osx binds DNA. A recombinant Osx polypeptide
S194 B cells, and PC12 cells (data not shown). (amino acids 27–428) was generated by transfection of
The Osx cDNA obtained by subtraction was used to an Osx expression vector into COS-7 cells. One major
identify larger cDNAs, the sequences of which showed complex was formed with extracts of Osx-transfected
an open reading frame of 1284 nucleotides and were cells and a double-stranded oligonucleotide containing
capable of encoding a 428 amino acid polypeptide with a consensus Sp1 binding site (Figure 1A, lanes 9–13).
a predicted molecular weight of 44.7 kDa. Formation of this complex was abolished by incubation
To examine the size of the corresponding endogenous with anti-C-terminal Osx antibodies (Figure 1A, lanes
polypeptide, antibodies were raised against a 14 amino 14–16), but binding to DNA was restored by addition of
acid peptide located at the C terminus of the deduced the C-terminal peptide that was used to generate these
polypeptide sequence. The purified antibodies recog- antibodies (Figure 1A, lanes 17 and 18), indicating that
nized a 46 kDa protein present in extracts of C2C12 the DNA-protein complex consisted of recombinant Osx
cells treated with BMP-2 but not in extracts of untreated and labeled probe. Osx also bound strongly but with
cells. The size of this polypeptide was in agreement with different efficiencies to several other functional G/C-rich
that predicted from the deduced amino acid sequence sequences, including those of the EKLF consensus site
of Osx, strongly suggesting that our cDNA encoded the and Sp1-like sequences in the Col1a1 and Col2a1 pro-
full-length Osx polypeptide. moters (Figure 1B). G to T mutations in two adjacent
The Osx amino acid sequence predicted the existence residues of a G/C-rich binding site abolished Osx bind-
of three C2H2-type zinc fingers at the C terminus of ing (data not shown). Thus, our results suggested that
Osx. This 85 amino acid zinc finger motif had a high Osx was a sequence-specific DNA binding protein.
degree of homology with the motifs present in the tran- To verify whether Osx contained a transcription acti-
scription factors Sp1, Sp3, and Sp4, and had a some- vation domain, various segments of the protein were
what lower homology with those in other transcription fused in frame with the DNA binding domain of the yeast
factors of the Kru¨ppel-like transcription factor family. transcription factor GAL4. The expression vectors were
Upstream of the zinc finger domain was a stretch of transfected into COS-7 cells with a reporter gene con-
basic amino acids similar to those in a region of EGR-1 taining five tandem GAL4 binding sites. A plasmid ex-
that has been shown to be important for nuclear localiza- pressing the GAL4 DNA binding domain was transfected
tion (Gashler et al., 1993). Therefore, we concluded that as a control. Figure 1C shows that the segment con-
Osx was a novel polypeptide with features typical of a taining residues 27–270 and the smaller proline/serine-
transcription factor. rich segment from residues 27–192 provided strong
transcriptional activation. Neither the near full-length
protein (residues 27–428) nor the zinc finger region ofExpression Pattern of Osx
To identify the cell types that expressed Osx in vivo, we Osx (residues 293–428) had appreciable transcriptional
activity when fused to GAL4. Figure 1D shows that theperformed in situ hybridization with mouse embryos at
various stages of development and with tissues from expression levels of the fusion polypeptides were similar
except for the fusion containing residues 27–192, whichnewborn mice (for detailed results, see Supplemental
Data at http://www.cell.com/cgi/content/full/108/1/17/ was expressed at a lower level. Thus, our experiments
indicated that Osx contained a strong transcription acti-DC1). In brief, Osx transcripts were first found transiently
in differentiating chondrocytes and in the surrounding vation domain.
To test the subcellular localization of Osx polypep-perichondrium of E13.5 embryos, but were not detected
in the condensed chondrogenic mesenchyme. Rapidly tides, COS-7 cells were transfected with a Flag-tagged
Osx expression vector and were examined by immuno-thereafter, transcripts were confined mainly to the pe-
ripheral layers of endochondral skeletal elements and fluorescence using anti-Flag antibodies. In these experi-
ments, Osx’s localization was restricted to the nucleuswere absent from more centrally located chondrocytic
cells. At E15.5 and later, strong expression was found (Figure 1E). Thus, on the basis of Osx’s DNA binding
properties, its transcription activation domain, and itsin cells associated with all bone trabeculae and in those
associated with formation of bone collars. Weak expres- subcellular localization, we concluded that it had the
properties of a typical transcription factor.sion was detected in the prehypertrophic zone, but not
in other cells of growth plate cartilage. Mesenchymal To test whether Osx could activate typical osteoblast
Osterix Is Required for Bone Formation
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Figure 1. DNA Binding, Transcriptional Activity, and Cellular Localization of Osx
(A) EMSA using a consensus Sp1 binding site as probe, without (lanes 1, 8, and 19) or with extracts of COS-7 cells transfected with empty
expression vector (lanes 2–7) or an Osx expression vector (lanes 9–18). DNA binding in the absence (lanes 1–4, 8, 9–13, and 19) or presence
(lanes 5–7 and 14–18) of purified anti-Osx antibodies. To show antibody specificity, the binding reaction was performed in the presence of
N-terminal peptide (1.5 g: lanes 3, 6, 11, and 16, 0.5 g: lanes 10 and 15) or C-terminal peptide (1.5 g: lanes 4, 7, 13, and 18, 0.5 g: lanes
12 and 17), which was used to generate antibodies. Arrows indicate specific complexes containing recombinant Osx proteins.
(B) Labeled, double-stranded oligonucleotides containing different G/C-rich sequences were used as probes, without (lanes 1, 4, 7, and 13)
or with extracts of COS-7 cells transfected with an empty expression vector (lanes 2, 5, 8, and 14) or an Osx expression vector (lanes 3, 6,
8, and 15). DNA sequences of C-rich strands of oligonucleotides used were: Sp1, 5-GCT CGC CCC GCC CCG ATC GAA T-3; EKLF, 5-CGT
AGA GCC ACA CCC TGA AGG-3; Col1a1A, 5-TCC ACC CAG CGC GCC CCC CCT CCC GCA A-3; Col1a1B, 5-CCT TCC TTT CCC TCC
TCC CCC CTC TTC G-3; MD25, 5-TAA CCT GAG ACC CCG CCC CCG GAG CCC-3.
(C) Segments of Osx were fused in frame with the GAL4 DNA binding domain and transiently transfected into COS-7 cells with a luciferase-
reporter plasmid. Numbers show relative luciferase activity after normalization for -gal activity.
(D) Western blot performed to monitor expression of GAL4-fusion polypeptides in COS-7 cells using antibodies to the DNA binding domain
of GAL4.
(E) Nuclear localization of the recombinant Osx. Flag-tagged Osx protein was expressed in COS-7 cells and immunostained with (panel 2) or
without (panel 4) anti-Flag antibodies, followed by incubation with Texas red-conjugated anti-mouse IgG antibodies. DAPI staining (panels 1
and 3) was performed to visualize nuclei in the identical fields shown in panels 2 and 4. Panels 1 and 2: 20, Panels 3 and 4: 10.
(F) C2C12 and C3H10T1/2 cells were transfected with an Osx expression vector (3 g), and incubated for 48 hr. Northern hybridization was
performed with osteocalcin and GAPDH probes.
(G) C2C12 cells were transfected with an Osx expression vector (3 g), and incubated for 24 hr. Northern hybridization was performed with
Col1a1 and GAPDH probes.
genes, we transfected an Osx expressing vector into To determine the chromosomal location of the Osx
gene in the mouse genome, a interspecific mappingboth C2C12 and C3H10T1/2 cells. Our results showed
that Osx produced an induction of osteocalcin RNA in panel of 94 DNA samples obtained from The Jackson
Laboratory was analyzed. The results indicated that theboth cell types (Figure 1F). In addition, Osx activated type
I collagen gene expression in C2C12 cells (Figure 1G). Osx gene (symbol Sp7) was located on mouse chromo-
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some 15 between Wnt10b and Itga5. Based on this chro- were compared (Figures 2L and 2M). The defects in
mineralization were already visible in E14.5 Osx null mu-mosomal location, the predicted syntenic region for the
human SP7 gene was chromosome 12q13. No inherited tants (data not shown), the same time when ossification
centers first began to form in wild-type embryos.skeletal disease has been mapped to this region.
Histological Analysis of Osx Null MutantsInactivation of the Osx Gene
Wild-type E16.5 mandible and maxilla showed typicalTo better understand the function of Osx, we inactivated
trabeculae and the presence of mineralization, as de-the Osx gene in mouse embryonic stem (ES) cells using
tected by von Kossa’s staining (Figures 3A1 and 3B1).homologous recombination. The Osx gene contained
In the null mutants, however, only condensed mesen-only two exons. Except for the DNA sequence encoding
chymal cells were present at these locations, and nothe seven N-terminal amino acids of Osx, the rest of the
bone trabeculae or mineralization were detectable (Fig-coding sequence was present in exon 2. Our targeting
ures 3A2 and 3B2). Identical observations were madestrategy (Figure 2A), which deleted most of the coding
between wild-type and mutant mice in other membra-sequence of exon 2, functionally inactivated the Osx
nous skeletal elements, such as frontal bones (data notgene. Insertion of the lacZ gene predicted that expres-
shown). The cellular organization of the tooth germ,sion of -galactosidase (-gal) would follow an Osx ex-
Meckel’s cartilage, and the musculus masseter was in-pression pattern. Mice were genotyped by both South-
distinguishable between wild-type and mutant mice.ern hybridization (Figure 2B) and by PCR amplification
The humerus of E16.5 wild-type mice displayed typical(Figure 2C). The absence of Osx RNA in northern blot
cellular organization of growth plate chondrocytes andexperiments using a probe 3 to the Osx deletion in
characteristic bone trabeculae of the ossification zone,E17.5 homozygous mutant embryo indicated that the
as well as mineralization of the bone trabeculae, collars,mutation was a null mutation (Figure 2D). Heterozygous
and the zone of hypertrophic chondrocytes close toOsx mutant mice were normal and fertile. Homozygous
the chondroosseous junction (Figures 3A3 and 3B3). InOsx mutant mice, which were recovered with the ex-
contrast, the humerus of E16.5 Osx null mutants had nopected Mendelian ratio, died in the immediate postnatal
bone trabeculae. Instead, a wedge-shaped mesen-period. These mice had difficulty in breathing, rapidly
chyme containing red blood cells emerged from thebecame cyanotic, and died within 15 min of birth. New-
central part of the periosteum (Figure 3A4), implying thatborn homozygous mutant mice showed severe inward
blood vessels were also present. No mineralization wasbending of forelimbs and hindlimbs (Figure 2E, arrows).
seen in the wedge-shaped mesenchyme. Similarly, noX-gal staining of E14.5 embryos showed that the pat-
mineral deposition occurred in the inner layer of thetern of-gal expression was very similar in heterozygous
periosteum/perichondrium, indicating that no bone col-and homozygous Osx mutants and faithfully reproduced
lar formed. However, mineral deposition was present inthe pattern of expression of the endogenous Osx gene
the alcian blue-stained matrix of the zone of the hyper-(Figure 2F). X-gal staining was undetectable in E12.5
trophic chondrocytes adjacent to the wedge-shapedembryos, but it was clearly evident by E13.5 (data not
mesenchyme (Figure 3B4), accounting for the alizarinshown). Skeletal preparations of E15.5 Osx null embryos
red staining observed in whole-mount skeletal prepara-showed that cartilage developed well and prefigured all
tions at this time of embryonic development (data notendochondral skeletal elements, as observed by alcian
shown). The abnormalities in the humerus were presentblue staining. No bending was observed in the forelimbs
in all other endochondral skeletal elements (data notand hindlimbs at this stage of development (Figure 2G,
shown).arrows). These results indicate that no patterning de-
In E14.5 Osx null membranous skeletal elements, con-fects were present in Osx null mutant embryos.
densed mesenchymal cells were -gal positive. SinceHowever, practically no mineralization was detected
these cells occupied the same space as they did inby alizarin red staining in E15.5 Osx null mutant embryos
wild-type embryos, they had migrated to their correct(Figure 2G). Staining of skeletal preparations from new-
location in the mutants and had presumably respondedborn homozygous mutant mice with alcian blue and
to the same signals as did wild-type cells (Figures 3C1–alizarin red indicated a virtual absence of mineralization
3C4). Mesenchymal cells in the periosteum/perichon-in all facial and skull bones formed by intramembranous
drium and in the wedge-shaped mesenchyme of the Osxossification (Figure 2H), whereas supraoccipital, exo-
null humerus also expressed -gal (Figure 3C4). Theseocipital, basioccipital, basisphonoid, and sphenoid
-gal expression patterns were reproduced in E17.5 het-bones of the chondrocranium (Figure 2I), which are
erozygous and homozygous mutant mice (data notformed by endochondral ossification, were stained by
shown).alizarin red. The clavicles were extremely hypoplastic
(Figure 2J). Other skeletal elements formed by endo-
chondral ossification, including the ribs, limb bones, and Expression of Osteoblast Markers
To better characterize the abnormalities of Osx mutantvertebrae, were hypoplastic, bent, and often deformed,
but no irregular fusion of joints occurred. Comparison mice, we examined the expression of several early and
late osteoblast marker genes by in situ hybridization.of alizarin red staining of different endochondral skeletal
elements indicated that mineralization was delayed and Type I collagen, which is the most abundant protein in
bone matrix (Bilezikian et al., 1996), is an early marker oftook place within cartilage of the mutant mice, sug-
gesting that no bone collar formed in the mutants (Fig- osteoblast differentiation. In E16.5 wild-type embryos,
Col1a1 RNA levels were much higher in osteoblasts thanures 2G, 2K, 2L, 2M, and 2N). This is best illustrated
when the wild-type and mutant hyoid skeletal elements in fibroblasts of the skin and mesenchymal cells (Figures
Osterix Is Required for Bone Formation
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Figure 2. Generation of Osx Mutant Mice and Analysis of Their Skeletal Phenotype
(A) Structure of the genomic Osx locus, targeting vector, and mutated allele after homologous recombination. Exons are depicted as closed
boxes. IRES-LacZ/PGK-neo casetttes are depicted as open boxes. Xh, XhoI; N, NheI; H, HindIII; Xb, XbaI, RI, EcoRI; 718, Asp718; RV, EcoRV.
(B) Southern blot analysis of fetal genomic DNA. Genomic DNA isolated from the tail was digested with EcoRI or EcoRV and then hybridized
with the 5 probe or the 3 probe, respectively. The wild-type and mutant alleles were detected as 12 kb and 5.7 kb fragments, respectively,
with the 5 probe, and as 18 kb and 12 kb fragments with the 3 probe.
(C) PCR genotyping was performed using two sets of primers: Osx5 (green arrow in A) and Osx3 (red arrow in A) for the wild-type allele and
bpA (black arrow in A) and Osx3 for the mutant allele.
(D) Northern blot analysis of Osx expression in wild-type and mutant mice. Ten micrograms of total RNA isolated from E17.5 wild-type,
heterozygous mutant and homozygous mutant embryos were hybridized with a 0.5 kb Osx cDNA probe.
In (E) and (G)–(N), upper panels show wild-type mice and lower panels homozygous mutant mice. Bars in (E)–(H) indicate 5 mm.
(E) Gross appearance of newborn embryos. The homozygous mutants show inward bending of limbs (arrows).
(F) -gal activity in heterozygous (upper) and homozygous mutant (lower) mice at E14.5.
(G) Skeletons of E15.5 mice stained by alcian blue followed by alizarin red. Limbs of mutant embryos show no bending (arrows).
(H) Skeletons of newborn mice. Distal limbs of mutant mice show bending (arrows).
(I–N) Ventral view of skulls (I), clavicles (J), humeri (K), hyoid bones (L) and a higher magnification of the mineralized part of the hyoid bones
(M), and palms (N).
3D1 and 3D3). In contrast, in Osx null mutant embryos, al., 1992), was seen in all bones of wild-type embryos
(Figures 3E1 and 3E3). In contrast, it was undetectablethe Col1a1 RNA levels in the condensed mesenchyme
of the membranous skeleton and in the periosteum and in the condensed mesenchyme of membranous and en-
dochondral skeletal elements and in the periosteum ofthe wedge-shaped mesenchyme of the endochondral
skeleton were severely reduced, expressed at levels Osx null mutants (Figures 3E2 and 3E4). Transcripts for
osteonectin and osteopontin, two other osteoblast mark-similar to those in skin fibroblasts (Figures 3D2 and 3D4).
Expression of the gene for Bone Sialoprotein (BSP), an- ers, were undetectable in the condensed mesenchyme
substituting for osteoblasts in E16.5 Osx null embryosother early marker of osteoblast differentiation (Chen et
Cell
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Figure 3. Histological Examination of Mutant Mice
Panels (1) and (2) show coronal sections of the skull, and panels (3) and (4) show the humerus. Panels (1) and (3) show wild-type embryos,
and panels (2) and (4) show homozygous mutant embryos. In panel (C), (C1) and (C3) show heterozygous mutant embryos.
(A) View of the maxilla, mandible, and humerus at E16.5. Sections were stained with alcian blue and counterstained with hematoxylin and
Osterix Is Required for Bone Formation
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Figure 4. Expression of Osx in Runx2/Cbfa1
Null Mice
(A) The proximal growth plate of the humerus
of wild-type-mice stained with alcian blue,
hematoxylin, and Treosin. (C) The middle part
of the tibia of Runx2/Cbfa1 null mice stained
with hematoxylin and eosin. Neighboring sec-
tions of wild-type humerus (B) and of Runx2/
Cbfa1 null tibia (D) were hybridized with the
Osx probe. Chondrocytes and cells in thin
perichondrium showed no expression of Osx
in Runx2/Cbfa1 null mice.
(data not shown). In wild-type E16.5 embryos, Runx2/ Cbfa1 and Osx belonged to two independent pathways
that controlled osteoblast differentiation or that bothCbfa1, which is required for osteoblast differentiation,
was expressed in all osteoblasts. In Osx null mutants, transcription factors were functioning in the same path-
way. To distinguish between these two possibilities, weRunx2/Cbfa1 was expressed at levels comparable to
those found in wild-type osteoblasts in the condensed asked whether Osx was expressed in Runx2/Cbfa1 null
mice. Figure 4D shows that no Osx transcripts weremesenchymal cells of membranous skeletal elements
and in the periosteum and the wedge-shaped mesen- detected in the periosteum of endochondral skeletal
elements of Runx2/Cbfa1 null mice. Thus, these resultschyme of the endochondral skeleton (Figures 3F1–3F4).
These same results had already been observed in E14.5 indicated that Osx was downstream of Runx2/Cbfa1
in the pathway of osteoblast differentiation and thatembryos, the developmental stage when ossification
was first initiated in wild-type embryos (data not shown). Runx2/Cbfa1 was needed for Osx expression.
In E18.5 Osx null embryos, expression of RNA for
osteocalcin, a late osteoblast marker and the most cell- Presence of Osteoclasts in Osx Null Mutants
Whereas no invasion of the zone of hypertrophic chon-specific one, was also absent in endochondral and
membranous skeletal elements (Figures 3G2 and 3G4). drocyte occurs in Runx2/Cbfa1 null mice (Figure 4C)
(Komori et al., 1997), there was extensive migration ofIn addition, transcripts for BSP, osteonectin, and osteo-
pontin were absent in the periosteum of E18.5 Osx mu- the mesenchymal cells into the mineralized cartilage
matrix in Osx null mice (Figure 5A). In wild-type mice,tants (data not shown). Thus, early markers of osteoblast
differentiation were not expressed at late stages of osteoblasts produce a typical eosinophilic bone matrix
using remnants of the degraded mineralized cartilagemouse development. We concluded that in Osx null em-
bryos, despite the presence of Runx2/Cbfa1 expression septae as a template (Figure 5B). In the E18.5 Osx null
humerus, remnants of degraded mineralized septae ofat levels comparable to those in wild-type embryos, both
early and late markers of osteoblast differentiation were hypertrophic chondrocytes were clearly visible by alcian
blue staining (Figure 5C). In contrast to those in wild-absent and, thus, osteoblast differentiation was com-
pletely arrested. type humerus, these remnants were not surrounded by
bone matrix, as detected by Treosin staining.Normal levels of Runx2/Cbfa1 expression in Osx null
mutants indicated that Osx was not required for Runx2/ To determine whether osteoclasts were involved in
the degradation of the mineralized cartilage matrix ofCbfa1 expression and suggested either that Runx2/
Treosin. In mutant mice, densely packed mesenchymal cells surround Meckel’s cartilage and tooth germs in the jaws and are present as a
wedge-shaped mesenchyme in the humerus.
(B) Staining by von Kossa’s method visualizes mineral deposition in the maxilla and mandible and humeri in wild-type and mutant mice at
E16.5. Maxilla and mandible show no mineralization in mutant mice. Mineralization of the humerus occurs only within the alcian blue-positive
hypertrophic chondrocyte matrix shown in (A). No mineralization was detected in the perichondrium/periosteum layer.
(C) Localization of -gal-expressing cells in E14.5 embryos. -gal-expressing cells were stained blue by whole mount X-gal staining and
mineral deposition was detected by von Kossa’s method. In heterozygous mice, mineral deposition occurs within matrix associated with
-gal-expressing cells (C1 and C3), which is lacking in mutant mice (C2 and C4).
(D–F) Expression of the Col1a1 gene (D), the BSP gene (E), and the Runx2/Cbfa1 gene (F) in E16.5 embryos.
(G) Expression of the osteocalcin gene in embryos at E18.5.
Cell
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Figure 5. Matrix Degradation and Osteo-
clastogenesis in Osx Null Mice
(A) Alcian blue, hematoxylin, and Treosin
staining of the proximal growth plate of the
humerus in a newborn Osx null mice. Arrows
indicate migration of mesenchymal cells.
(B) Alcian blue, hematoxylin, and Treosin
staining of a wild-type proximal growth plate
of the humerus shows eosinophilic matrix ac-
cumulation corresponding to bone matrix de-
position around the alcian blue-stained de-
graded cartilaginous matrix.
(C) No such eosinophilic deposition occurs in
the homozygous mutant.
(D) TRAP staining of the humerus of a homo-
zygous mutant at E14.5 reveals TRAP-posi-
tive cells in the middle of the fibrous layer of
the perichondrium.
(E) At E16.5, eosinophilic cells, together with
red blood cells, localize to the interface of the
cartilage and the mesenchyme.
(F–J) (F) High magnification of (E): a multinu-
cleated eosinophilic cell extending cellular
processes into the cartilage matrix. At E18.5,
TRAP-positive cells localize within the carti-
lage matrix produced by hypertrophic chon-
drocytes (G) and within the condensed mes-
enchyme of the mandible (H). Expression of
MMP-9 (I) and cathepsin K (J) detected by
immunostaining in cells migrating into the
cartilage matrix.
Osx null mutants, we examined whether tartrate-resis- present in Osx null newborn mice, suggesting that the
TRAP-positive cells in these mutants were functionaltant acid phosphatase (TRAP)-positive cells were pres-
ent. In E14.5 Osx null embryos, TRAP-positive cells were osteoclasts (Figures 5I and 5J). These results indicated
that, in contrast to the Runx2/Cbfa1 null mutants indetected within the periosteum of endochondral skeletal
elements (Figure 5D). Figures 5E and 5F show that in which only mononucleated TRAP-positive cells were
seen in the periosteum, multinucleated functional osteo-the humerus of E16.5 Osx null mutants, multinucleated
cells were present, together with red blood cells, at the clasts were observed in the cartilage matrix in Osx null
mutants.boundary between invading mesenchymal cells and the
matrix of hypertrophic chondrocytes. In mutant E18.5
embryos and newborn mice, TRAP-positive cells were Fate of Osx Null Mutant Cells
Given that osteoblast differentiation was arrested in Osxfound within the degraded hypertrophic cartilage matrix
(Figure 5G). Similarly, TRAP-positive multinucleated null mutant cells and that the cells expressed levels of
Runx2/Cbfa1 comparable to those in wild-type osteo-cells were seen among the mesenchymal cells of the
mandibular skeletal element of newborn Osx null mice blasts, we asked whether the Osx null mutant cells could
adopt a different cell fate. This was first suggested by(Figure 5H). MMP-9 (Vu et al., 1998) and cathepsin K
(Gowen et al., 1999), which are osteoclast markers, were the observation that alcian blue stained the matrix in
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Figure 6. Expression of Chondrocyte Markers in Homozygous Mutant Mice
Alcian blue, hematoxylin, and Treosin staining of the homozygous mutant humerus (A) and the lower jaw (B) at E18.5 showing ectopic
differentiation of chondrocytes in condensed mesenchymes. In the humerus, round cells with alcian blue positive matrix (A, arrow) appeared
in inner layer of perichondrium. In the lower jaw, an adjacent region of the condensed mesenchyme to the Meckel’s cartilage (red arrow) is
stained by alcian blue (white arrow). (C) and (D) are neighboring sections of (A) and (B), respectively, stained by von Kossa’s method. (E), (G),
(I ), (K), and (M) show humerus in E16.5 wild-type mice. (O) and (Q) show skull and jaw, respectively, in E18.5 wild-type mice. (F), (H), (J), (L),
and (N) show humerus in E16.5 homozygous mice. (P) and (R) show skull and jaw, respectively, in E18.5 homozygous mice. (E and F) Expression
of Sox9. (G and H) Expression of Sox5. (I and J) Expression of Col2a1. (M and N) Expression of Col10a1. (K, L, O, P, Q and R) Expression
of Ihh.
the mesenchyme in membranous skeletal primordia and for the small amounts of alizarin red staining seen in the
mandibular region outside of the Meckel’s cartilage incells in the wedge-like mesenchyme in endochondral
skeletal elements of E18.5 Osx null embryos (Figures 6A newborn Osx null mice (Figure 2H).
We therefore examined expression of molecular mark-and 6B). Moreover, cells embedded in an alcian blue-
stained matrix had a round shape characteristic of chon- ers of chondrocyte differentiation in the mutant cells in
E16.5 null mutant mice. The cells in the wedge-shapeddrocytes. Some of the cells were capable of mineralizing
their matrix (Figures 6C and 6D). This also accounted mesenchyme of Osx null endochondral skeletal ele-
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ments expressed Sox9, Sox5, Col2a1, and Ihh tran- embryonic development. Osx contains a DNA binding
domain consisting of three C2H2-type zinc fingers at itsscripts (Figures 6F, 6H, 6J, and 6L). Similarly, Osx null
membranous skeletal elements showed ectopic expres- C terminus that share a high degree of identity with
motifs in Sp1, Sp3, and Sp4. Somewhat less identity ission of these transcripts (Figures 6P and 6R, and data
not shown). In the humerus of E16.5 Osx null mutants, shared with motifs in FKLF2 (Asano et al., 2000), BTEB1
(Imataka et al., 1992), and other members of the Kru¨ppel-expression of Col10a1, which was seen in hypertrophic
chondrocytes of the cartilage growth plate (Figure 6N), like factor family (Philipsen and Suske, 1999; Turner and
Crossley, 1999). Osx binds to Sp1 and EKLF consensuswas still largely excluded from the cells of the wedge-
shaped mesenchyme that ectopically expressed Sox9, sequences and to other G/C-rich sequences. Such G/C-
rich sequences are present in many promoters, includ-Sox5, Col2a1, and Ihh. Overall these results indicated
that Runx2/Cbfa1-expressing Osx null cells, which could ing those corresponding to the genes that are inactive
in Osx null embryos (Hafner et al., 1995; Karsenty andnot differentiate into osteoblasts, acquired a cell fate
characterized by the expression of a series of genes de Crombrugghe, 1991; Ogata et al., 1997). Osx also
contains a proline- and serine-rich transcription activa-that are typical of chondrocytes.
tion domain, as do several other members of the XKLF
family (Philipsen and Suske, 1999). However, the aminoDiscussion
acid sequence of Osx outside of its DNA binding domain
shares no significant similarity with any other human,Osx Is Essential for Osteoblast Differentiation
mouse, Drosophila, or Caenorhabditis elegans polypep-Our results established that the novel transcription fac-
tide. This is in agreement with the phenotype of Osxtor Osx is required for osteoblast differentiation and
null mice, indicating that no other mouse protein canhence for bone formation. In the absence of Osx, no
substitute for the function of Osx in osteoblast differenti-cortical bone and no bone trabeculae were formed
ation.through either intramembranous or endochondral ossifi-
cation. During normal endochondral bone formation, the
degradation of the mineralized cartilage matrix by osteo- Osx Acts Downstream of Runx2/Cbfa1
Osteogenic cells of Osx null mutants that were com-clasts/chondroclasts and the deposition of a character-
istic bone matrix by osteoblasts are tightly coordinated. pletely blocked in their differentiation into osteoblasts
expressed Runx2/Cbfa1 at levels comparable to thoseIn endochondral skeletal elements of Osx null mutants,
mesenchymal cells from the perichondrium/periosteum, in wild-type osteoblasts. Hence, Osx was not required
for Runx2/Cbfa1 expression. Since Osx was not ex-together with blood vessels, invaded the mineralized
matrix of the zone of hypertrophic chondrocytes. More- pressed in Runx2/Cbfa1-defective embryos, we con-
cluded that expression of Osx required Runx2/Cbfa1over, the presence of multinucleated osteoclasts in the
mineralized cartilage matrix of Osx null mutants and and that Osx therefore acted downstream of Runx2/
Cbfa1. Although Runx2/Cbfa1 is needed for Osx expres-degradation of this matrix indicated that osteoclast dif-
ferentiation and active cartilage matrix degradation were sion in osteogenic cells, Osx is not expressed in hyper-
trophic chondrocytes despite expression of Runx2/taking place. This was further supported by the demon-
stration of cells expressing MMP-9 and cathepsin K in Cbfa1 in these cells. The levels of Runx2/Cbfa1 may be
insufficient in hypertrophic chondrocytes, and/or Osxthe hypertrophic cartilage matrix. However, mesenchy-
mal cells migrating together with osteoclasts and blood expression may require additional transcription factors
that are missing in hypertrophic chondrocytes.vessels could not deposit bone matrix, so no ossification
could occur in the matrix of this mesenchyme. Similarly,
no ossification took place in the condensed mesen- The Phenotype of Osx Mutants Is Different
chyme of membranous skeletal elements. The degraded than That of Runx2/Cbfa1 Mutants
mineralized cartilage matrix and the absence of bone Although the phenotypes of Osx null and Runx2/Cbfa1
matrix accounted for the severe bending of long bones. null mutants are both characterized by a lack of bone
In contrast to the absence of bone matrix, the cellular formation and by an absence of differentiated osteo-
organization of the cartilage growth plate was normal blasts, there are important differences in the phenotypes
in Osx null mutants except for the disordered organiza- of these mutants. In the humerus and femur of Runx2/
tion of the deep layers of the zone of hypertrophic chon- Cbfa1 null mice, markers of hypertrophic chondrocytes
drocytes. Furthermore, Osx appeared to have no role are not expressed (Inada et al., 1999). In addition, in
in patterning of the skeleton. Indeed, at E12.5, a time skeletal elements in which these markers are expressed,
when many of the patterning decisions of the embryonic very little mineralization of the ECM of hypertrophic
skeleton have been made, Osx null embryos were indis- chondrocytes occurs in Runx2/Cbfa1 null embryos,
tinguishable from wild-type embryos. In addition, in strongly suggesting that a mineralization defect exists
newborn mutants, densely packed mesenchymal cells in in the endochondral skeleton of Runx2/Cbfa1 null mice.
membranous skeletal elements, unable to differentiate Importantly, in Runx2/Cbfa1 null embryos, no invasion
into osteoblasts, occupied the same space as that occu- of the matrix of hypertrophic chondrocytes by cells of
pied by osteoblasts in wild-type embryos. the periosteum/perichondrium takes place, no osteo-
clasts/chondroclasts are found in the matrix, and no
matrix degradation occurs (Komori et al., 1997). Notably,Osx Is a Novel Transcription Factor Belonging
to the Sp/XKLF Family Osx was not expressed in hypertrophic chondrocytes
in our study, and both the levels of expression of Col10alConsistent with the phenotype of Osx null mutants, the
Osx gene is expressed in all osteoblasts during mouse and Ihh and the aspect of hypertrophic chondrocytes
Osterix Is Required for Bone Formation
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were normal in Osx null mutants. In addition, mineraliza-
tion of the hypertrophic zone was much more pro-
nounced in Osx null embryos than in Runx2/Cbfa1 null
embryos. It should also be noted that the abundant
wedge-shaped mesenchyme in Osx null embryos con-
trasted with the thin mesenchyme in the periosteum in
Runx2/Cbfa1 null embryos.
Interestingly, ectopic expression of Runx2/Cbfa1, di-
rected by Col2a1 regulatory elements in Runx2/Cbfa1
null embryos, leads to a partial rescue of the phenotype
of Runx2/Cbfa1 null embryos (Takeda et al., 2001). This
Figure 7. Model of Osteoblast Differentiation Pathwaypartial rescue includes hypertrophic chondrocyte differ-
entiation in endochondral skeletal elements in which Multipotential mesenchymal progenitors first differentiate into pre-
osteoblasts, a process for which Runx2/Cbfa1 is needed. Thesesuch differentiation is defective in the parent Runx2/
preosteoblasts are still bipotential; i.e., they have the potential toCbfa1 null embryos, VEGF expression by hypertrophic
differentiate into both osteoblast and chondrocytes. Preosteoblastschondrocytes, vascular invasion of the zone of hypertro-
do not express osteoblast marker genes, except low levels of Col1a1
phic chondrocytes, and the presence of multinucleated typical of mesenchymal cells. Preosteoblasts then differentiate into
TRAP-positive cells in the hypertrophic cartilage matrix. functional osteoblasts expressing high levels of osteoblast marker
All these processes were absent in Runx2/Cbfa1 null genes. This process requires Osx.
embryos. However, no bone formation and no osteo-
blast differentiation occurred in rescued embryos. Thus,
Runx2/Cbfa1 has two very distinct functions in bone an essential role in this process (Figure 7). These preos-
formation. First, it has an essential role in the differentia- teoblasts do not express osteoblast marker genes. Be-
tion of mesenchymal progenitors into osteoblasts in cause in both the membranous and endochondral skele-
both the endochondral and membranous skeletons. The tons, Osx null preosteoblasts, which are blocked from
second function of Runx2/Cbfa1 is to stimulate hyper- differentiating into osteoblasts, express several chon-
trophic chondrocyte differentiation. The phenotype of drocyte marker genes, including Sox9, Sox5, Col2a1,
Runx2/Cbfa1 null mice is the result of the abolition of and Ihh, we postulate that preosteoblasts are still bipo-
both functions. In contrast, in Osx null embryos, the lack tential. This bipotentiality implies that the progenitors
of bone formation appears to be caused entirely by an of these cells also have the potential to differentiate into
inability of osteoblasts to differentiate. osteoblasts and chondrocytes. In both endochondral
There are several possible explanations for the absent and intramembranous skeletal elements, the Runx2/
expression of almost all osteoblast marker genes in Osx Cbfa1-expressing preosteoblasts then differentiate in
null mutants, despite levels of expression of Runx2/ one or more steps into mature osteoblasts and express
Cbfa1 that are comparable to those present in wild- characteristic osteoblast marker genes, a process that
type osteoblasts. Several of these marker genes contain requires Osx. It is possible that Runx2/Cbfa1 and other
Runx2/Cbfa1 binding sites in their promoters and muta- transcription factors collaborate with Osx to activate
tions in these sites (Benson et al., 1999; Ducy et al., these osteoblast marker genes in vivo to produce a
1997; Sato et al., 1998), which abolished the binding of bone-specific matrix.
Runx2/Cbfa1, inhibited the activity of these promoters Our experiments provide strong evidence supporting
in transient expression experiments, consistent with the the hypothesis that osteoblasts and chondrocytes de-
hypothesis that these genes might be direct targets of rive from a common precursor cell. Interestingly, the
Runx2/Cbfa1. Although one cannot exclude that the in bipotentiality of the cells is maintained in Runx2/Cbfa1-
vivo function of Runx2/Cbfa1 to activate osteoblast expressing preosteoblasts that appear to be committed
marker genes is entirely mediated by Osx, we favor a to the osteoblast lineage. We speculate that in osteo-
model whereby several osteoblast marker genes need blasts, Osx might be a negative regulator of Sox9 and
both Osx and Runx2/Cbfa1 for their expression. Others Sox5 expression, preventing these cells from choosing
would require only Osx, whereas still other marker genes a chondrocyte differentiation pathway.
would require only Runx2/Cbfa1. It is further possible In summary, based on (1) the identification of Osx
that for the expression of some osteoblast-specific as a transcription factor that is essential for osteoblast
genes, Osx is the only factor required but Runx2/Cbfa1 differentiation, (2) the normal levels of expression of
could increase the activity of these genes. Our in vitro Runx2/Cbfa1 in Osx null mutant preosteoblasts, and (3)
experiments suggest that Osx is sufficient to activate the lack of Osx expression in Runx2/Cbfa1 null mice, our
the osteocalcin gene in both C2C12 and C3H10T1/2 results add a distinct step to the pathway of osteoblast
cells. In addition, Osx is also sufficient to activate Col1a1 differentiation.
gene in C2C12 cells.
Experimental Procedures
Pathway of Osteoblast Differentiation
Generation and Genotyping of Osx Mutant MiceOur experiments suggest the following model for osteo-
Osx genomic clones were isolated from a mouse 129/SvEv genomicblast differentiation. Osteoblast progenitors in mesen-
DNA library. The targeting vector was constructed by inserting an
chymal condensations of both endochondral and mem- IRES-lacZ-polyA/loxP-flanked PGK neo-bpA cassette into the sec-
branous skeletal elements first differentiate through one ond coding exon of Osx. An MC1tkpA (tk) expression was induced
for negative selection (Bi et al., 1999). AB-1 ES cell clones carryingor several steps into preosteoblasts; Runx2/Cbfa1 has
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an Osx mutation were identified by Southern blot analysis using Osx and signaling in cartilage development. Osteoarthritis Cartilage 8,
309–334.probes located outside the region used for homologous recombina-
tion. Mouse chimeras were generated by injection of mutant ES cell Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. (1997).
clones into C57BL/6 blastocysts. Mutant mice were analyzed in the Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.
C57BL/6 X 129/SvEv mixed genetic background. Homozygous null Cell 89, 747–754.
mice derived from three independent ES cell clones exhibited identi-
Fang, J., and Hall, B.K. (1997). Chondrogenic cell differentiation from
cal phenotypes. Mice were genotyped using genomic DNA isolated
membrane bone periostea. Anat. Embryol. 196, 349–362.
from the tails digested with EcoRI or EcoRV and hybridized with an
Gashler, A.L., Swaminathan, S., and Sukhatme, V.P. (1993). A novelNheI-ScaI probe (5 probe) or an Asp718-NheI probe (3 probe). The
repression module, an extensive activation domain, and a bipartitewild-type and mutant alleles were detected as 12 kb and 5.7 kb
nuclear localization signal defined in the immediate-early transcrip-fragments, respectively, with the 5 probe and as 18 kb and 12 kb
tion factor Egr-1. Mol. Cell. Biol. 13, 4556–4571.fragments, respectively, with the 3 probe. PCR genotyping was
Gowen, M., Lazner, F., Dodds, R., Kapadia, R., Feild, J., Tavaria,performed using two sets of primers: Osx5 and Osx3 for the wild-
M., Bertoncello, I., Drake, F., Zavarselk, S., Tellis, I., et al. (1999).type allele, and bpA and Osx3 for the mutant allele. Osx5/Osx3
Cathepsin K knockout mice develop osteopetrosis due to a deficitprimers and bpA/Osx3 primers yielded 286 bp and 395 bp PCR
in matrix degradation but not demineralization. J. Bone Miner. Res.fragments, respectively.
14, 1654–1663.
Analyses of Mutant Mice Hafner, M., Zimmermann, K., Pottgiesser, J., Krieg, T., and Nischt, R.
Whole-mount X-gal staining of embryo and alcian blue and alizarin (1995). A purine-rich sequence in the human BM-40 gene promoter
red staining of skeleton were performed as described (Hogan et al., region is a prerequisite for maximum transcription. Matrix Biol. 14,
1994). For histological analysis, paraformaldehyde-fixed, paraffin- 733–741.
embedded embryonic undecalcified tissue sections were stained Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). Manip-
with alcian blue, hematoxylin, and Treosin (StatLab). To detect min- ulating the Mouse Embryo, 2nd Edition (Cold Spring Harbor, NY:
eral deposition, tissue sections were stained with von Kossa’s Cold Spring Harbor Laboratory Press).
method followed by nuclear fast red counter staining. TRAP staining
Imataka, H., Sogawa, K., Yasumoto, K., Kikuchi, Y., Sasano, K.,
was performed using a leucocyte acid phosphatase kit (Sigma).
Kobayashi, A., Hayami, M., and Fujii-Kuriyama, Y. (1992). Two regu-
Immunodetection of MMP-9 and cathepsin K were performed using
latory proteins that bind to the basic transcription element (BTE), a
anti-MMP-9 (Chemicon) and anti-cathepsin K (Santa Cruz Biotech-
GC box sequence in the promoter region of the rat P-4501A1 gene.
nology) antibodies with a standard protocol (Ausubel et al., 1995).
EMBO J. 11, 3663–3671.
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